Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of antitumor pharmaceutical composition and its preparation method and application

A composition and anti-tumor technology, applied in the field of anti-tumor drugs, can solve problems such as difficult to effectively control adverse reactions of products, high safety risks of clinical medication, and poor drug compliance of patients

Active Publication Date: 2021-06-08
JIANGSU JIUXU PHARMA +1
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In order to reduce and avoid adverse reactions, the quality control of polyoxyethylene castor oil products has been strengthened at home and abroad. The product standards have been included in the pharmacopoeias of the United States, Europe, and China. The quality standard is difficult to effectively control the occurrence of adverse reactions of the product, the toxicity of related impurities is unknown, the safety risk of clinical medication is high, and the patient's medication compliance is very poor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of antitumor pharmaceutical composition and its preparation method and application
  • A kind of antitumor pharmaceutical composition and its preparation method and application
  • A kind of antitumor pharmaceutical composition and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Embodiment 1 polyoxyethylene castor oil refining method

[0047] Take 1 part by weight of polyoxyethylene castor oil and add 1.4 parts by weight of acetonitrile to dissolve it, add 1.4 parts by weight of cyclohexane to extract, stir at 150r / min for 15min, put it in a water bath at 30°C, and let it stand for stratification to obtain the acetonitrile solution of the lower layer; Acetonitrile solution, adding 1.4 parts by weight of cyclohexane for extraction, stirring at 150r / min for 15min, standing in a water bath at 60°C for stratification, and obtaining the lower layer of acetonitrile solution; repeating the extraction with cyclohexane for 4 times, and the final acetonitrile extract in In a water bath at 40°C, acetonitrile was removed by rotary evaporation to obtain refined polyoxyethylene castor oil.

Embodiment 2

[0048] Embodiment 2 polyoxyethylene castor oil refining method

[0049] Take 1 part by weight of polyoxyethylene castor oil and add 1.6 parts by weight of acetonitrile to dissolve it, add 1.6 parts by weight of cyclohexane to extract, stir at 150r / min for 15min, put it in a water bath at 55°C, and let it stand for stratification to obtain the acetonitrile solution of the lower layer; Acetonitrile solution, adding 1.6 parts by weight of cyclohexane for extraction, stirring at 150r / min for 15min, standing in a water bath at 55°C for stratification to obtain the lower layer of acetonitrile solution; repeated extraction with cyclohexane for 3 times, and the final acetonitrile extract in In a water bath at 55°C, remove acetonitrile by rotary evaporation to obtain refined polyoxyethylene castor oil.

Embodiment 3

[0050] Embodiment 3 polyoxyethylene castor oil refining method

[0051] Take 1 part by weight of polyoxyethylene castor oil and add 1.8 parts by weight of acetonitrile to dissolve it, add 1.8 parts by weight of cyclohexane to extract, stir at 150r / min for 15min, put it in a water bath at 60°C, and let it stand for stratification to obtain the acetonitrile solution of the lower layer; Acetonitrile solution, adding 1.8 parts by weight of cyclohexane for extraction, stirring at 150r / min for 15min, standing in a water bath at 30°C, standing for stratification to obtain the lower layer of acetonitrile solution; repeating the extraction with cyclohexane for 3 times, the final acetonitrile extract in In a water bath at 60°C, remove acetonitrile by rotary evaporation to obtain refined polyoxyethylene castor oil.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention relates to the technical field of anti-tumor drugs, in particular to an anti-tumor pharmaceutical composition and its preparation method and application. In order to reduce the incidence of serious adverse reactions of paclitaxel injection, improve drug safety and drug compliance of patients, the invention adopts an anti-tumor pharmaceutical composition made of refined polyoxyethylene castor oil. The comparison of impurities before and after refining polyoxyethylene castor oil showed that the content of impurities in polyoxyethylene castor oil at the retention time 0.6 and 1.2 relative to paclitaxel in the chromatogram of related substances in paclitaxel injection was significantly reduced, and the safety of polyoxyethylene castor oil was significantly improved after refining.

Description

technical field [0001] The invention relates to the technical field of anti-tumor drugs, in particular to an anti-tumor pharmaceutical composition and its preparation method and application. Background technique [0002] Paclitaxel is a tetracyclic diterpene amide compound, a secondary metabolite first extracted from the bark of Taxus chinensis. It is a natural anticancer drug with strong spectrum and activity. The injection Taxol developed by Bristol-Myers Squibb at the end of the 20th century was first used in clinical practice. Tubulin assembles into microtubules, but inhibits the depolymerization of microtubules and stabilizes microtubules, which leads to abnormal arrangement of microtubules, makes the pituitary gland lose its normal function and leads to cell death, and has outstanding curative effect on breast cancer and ovarian cancer. In addition, It also has a certain effect on liver cancer, lung cancer, esophageal cancer, head and neck cancer and prostate cancer, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K47/44A61K9/08A61K31/337A61K31/704A61K31/555A61P35/00
CPCA61K9/0019A61K9/08A61K31/337A61K31/555A61K31/704A61K47/44
Inventor 刘新红张明明于自勋毛黎静吴杰
Owner JIANGSU JIUXU PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com